Jump to Navigation

Facebook Connect

User login

Ancillary Course Info

REGISTER TODAY!

 

This intensive 2-day training course offers an in-depth review of the core curriculum in Clinical Lipidology for health care professionals who desire to practice at an advanced level within the field. Learn from leading experts, assess your knowledge of lipid science and advance your personal standard of practice.

The lectures are supplemented with Q&A sessions using an audience response system that facilitates interactive learning and in-depth coverage of the exam content areas. In addition, a complete syllabus with copies of the slides is provided to all participants. All paid attendees will receive access to a special web page providing downloadable resources and additional self-study materials.

Masters in Lipidology is offered as a 2-day course prior to each scientific meeting conducted by the NLA.

Course Curriculum:

Lipoprotein Metabolism, Genetics, and Familial Lipid Disorders
Vascular Biology and and Atherosclerosis Pathogenesis
Evidence Based Medicine, Cardiovascular Risk Assessment, and Practice Guidelines
Advanced Lipidology: Cardiovascular Biomarkers, Atherosclerosis Imaging, and Evidence Based Practice
Obesity, Metabolic Syndrome and Diabetes Mellitus
Nutrition and Non-Pharmacologic Therapy
Pharmacology Part I- Lipid Lowering Drugs, Drug Interactions, and Drug Safety
Pharmacology Part II- Randomized Controlled Trials, Evidence Based Treatment, and Combination Therapy
Complex Case and Consultative Lipidology 

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians with an interest in lipid management.

Upon completion of the educational activity, participants should be able to:

  1. Apply basic principles of evidence based medicine to enhance understanding of clinical trial results, methods for cardiovascular risk stratification, and applying new research into practice
  2. Assess the side effects of lipid-altering drugs to encourage their safe use in cardiovascular disease prevention
  3. Assess traditional and emerging biomarkers for the prevention and treatment of atherosclerotic cardiovascular disease
  4. Describe combination therapies for the management of complex lipid disorders and residual risk.
  5. Describe effective diet and lifestyle (exercise, weight management) strategies for the management of dyslipidemia and cardiovascular risk
  6. Describe genetic disorders affecting lipoprotein metabolism
  7. Describe the vascular biology and pathophysiology of atherosclerosis
  8. Explain clinical practice guidelines, the different types of evidence used to make clinical guidelines, and the role of clinical judgment in applying guidelines to practice
  9. Explain how obesity and adiposopathy contribute to the metabolic syndrome and diabetes mellitus
  10. Explain lipoprotein metabolism and its role in the pathogenesis of atherosclerosis
  11. For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families
  12. Identify how general dietary patterns and specific macronutrients (fats, carbohydrates) affect coronary heart disease and lipids
  13. Identify management strategies for the cardiometabolic risk factors of the metabolic syndrome
  14. Identify the evidence base that supports current dietary recommendations for heart health
  15. Manage complex dyslipidemia and dyslipidemia in special populations
  16. Outline current issues and approaches to global CV risk assessment;
  17. Review clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention
  18. Review the mechanism of action, pharmacokinetics, and efficacy of available FDA approved drugs for the management of lipid disorders
  19. Review the role of subclinical atherosclerosis testing (imaging) in cardiovascular disease risk assessment and management

The National Lipid Association is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 16 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.

CE Credit provided by The National Lipid Association
Pharmacists
The National Lipid Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Day 1 Morning Session - Universal Activity Number - 0624-0000-17-017-L01-P (Knowledge)
The National Lipid Association designates this continuing education activity for 4.00 contact hour(s) (.40 CEUs) of the Accreditation Council for Pharmacy Education.
Day 1 Afternoon Session - Universal Activity Number - 0624-0000-17-018-L01-P (Knowledge)
The National Lipid Association designates this continuing education activity for 4.50 contact hour(s) (.450 CEUs) of the Accreditation Council for Pharmacy Education.
Day 2 Morning Session - Universal Activity Number - 0624-0000-17-019-L01-P (Knowledge)
The National Lipid Association designates this continuing education activity for 5.00 contact hour(s) (.50 CEUs) of the Accreditation Council for Pharmacy Education.
Day 2 Afternoon Session - Universal Activity Number - 0624-0000-17-020-L01-P (Application)
The National Lipid Association designates this continuing education activity for 2.25 contact hour(s) (.225 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
This educational activity for 15.6 contact hours is provided by The National Lipid Association.
The National Lipid Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Day 1 Morning Session- 4.0 credits; Day 1 Afternoon Session- 4.5 credits; Day 2 Morning Session- 4.9 credits; Day 2 Afternoon Session- 2.2 credits.
Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Criteria for Success
Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/ claimed credit form at www.lipid.org/cme.

For Pharmacists:
Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

Disclosure Statement
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.

Commercial Support
Full notification of commercial support will be provided in the activity syllabus.

Harold E. Bays, MD, FTOS, FACC, FACE, FNLA

Medical Director/President
Louisville Metabolic and Atherosclerosis Research Center
Louisville, KY
Diplomate, American Board of Clinical Lipidology
Alan S. Brown, MD, FNLA

Director, Division of Cardiology
Advocate Lutheran General Hospital
Co-Director, Cardiology Service Line
Advocate Medical Group
Clinical Associate Professor, Loyola Stritch School of Medicine
Park Ridge, IL

 
Anne C. Goldberg, MD, FACP, FNLA

President, Foundation of the NLA
Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Diplomate, American Board of Clinical Lipidology
Terry A. Jacobson, MD, FACP, FAHA, FNLA

Professor of Medicine Director
Office of Health Promotion and Disease Prevention
Emory University
Atlanta, GA
Diplomate, American Board of Clinical Lipidology
Kevin C. Maki, PhD, FNLA, CLS

Chief Scientist
MB Clinical Research
Glen Ellyn and Chicago, IL
Boca Raton, FL
Diplomate, Accreditation Council for Clinical Lipidology
Carl E. Orringer, MD, FACC, FNLA

Associate Professor of Medicine
University of Miami
School of Medicine
Miami, FL
Diplomate, American Board of Clinical Lipidology

2017 Masters in Lipidology at Fall Clinical Lipid Update- Indianapolis

Thursday, August 10, 2017

Day 1

7:30 - 8:00 AM Registration & Breakfast

Add

8:00 - 10:00 AM Lipoprotein Metabolism, Genetics, and Familial Lipid Disorders Alan S. Brown, MD, FACC, FAHA, FNLA
10:00 - 11:00 AM Vascular Biology and Atherosclerosis Pathogenesis Alan S. Brown, MD, FACC, FAHA, FNLA
11:00 - 11:10 AM Break
11:10 - 12:10 Evidence-Based Medicine, Cardiovascular Risk Assessment and Practice Guidelines Kevin C. Maki, PhD, CLS, FNLA
12:10 - 12:40 PM Lunch
12:40 - 1:40 PM Advanced Lipidology: Cardiovascular Biomarkers and Atherosclerosis Imaging Kevin C. Maki, PhD, CLS, FNLA
1:40 - 2:50 PM Managing Diabetes Mellitus and Cardiometabolic Risk Harold E. Bays, MD, FTOS, FACC, FACE, FNLA
2:50 - 3:00 PM Break
3:00 - 4:50 PM Pharmacology Part I- Lipid Lowering Drugs, Drug Interactions, and Drug Safety Harold E. Bays, MD, FTOS, FACC, FACE, FNLA

Add

Friday, August 11, 2017

Day 2

7:00 - 7:30 AM Breakfast

Add

7:30 - 9:45 AM Pharmacology Part II- Randomized Controlled Trials, Evidence Based Treatment, and Combination Therapy Terry A. Jacobson, MD, FNLA
9:45 - 9:55 AM Break
9:55 - 11:40 AM Consultative Lipidology and Special Populations Carl E. Orringer, MD, FNLA
11:40 - 12:10 Lunch
12:10 - 1:50 PM Nutrition and Non-Pharmacologic Therapy Anne C. Goldberg, MD, FACP, FNLA
1:50 - 3:05 PM Complex Cases Terry A. Jacobson, MD, FNLA
3:05 - 3:25 PM Exam Info & Wrap-up Terry A. Jacobson, MD, FNLA

Add

Add



by Dr. Radut.